☰

Stella P. Kim, Ph.D. - Publications

Affiliations: 
2007 Physiology and Biophysics University of Southern California, Los Angeles, CA, United States 
Area:
Endocrinology/Metabolism, Diabetes
Tree Info Grants Similar researchers PubMed Report error

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Iyer MS, Paszkiewicz RL, Bergman RN, Richey JM, Woolcott OO, Asare Bediako I, Wu Q, Kim SP, Stefanovski D, Kolka CM, Clegg DJ, Kabir M. Activation of NPRs and UCP1-independent pathway following CB1R antagonist treatment is associated with adipose tissue beiging in fat-fed male dogs. American Journal of Physiology. Endocrinology and Metabolism. PMID 31237449 DOI: 10.1152/Ajpendo.00539.2018  0.703
2018 Asare-Bediako I, Paszkiewicz RL, Kim SP, Woolcott OO, Kolka CM, Burch MA, Kabir M, Bergman RN. Variability of Directly Measured First-Pass Hepatic Insulin Extraction and its Association With Insulin Sensitivity and Plasma Insulin. Diabetes. PMID 29752425 DOI: 10.2337/Db17-1520  0.719
2018 Asare-Bediako I, Paszkiewicz RL, Kim SP, Woolcott OO, Kolka CM, Burch M, Kabir M, Piccinini F, Bergman RN. Assessment of hepatic insulin extraction from in vivo surrogate methods of insulin clearance measurement. American Journal of Physiology. Endocrinology and Metabolism. PMID 29509434 DOI: 10.1152/Ajpendo.00344.2017  0.728
2018 PASZKIEWICZ RL, BERGMAN RN, BEDIAKO IA, MKRTCHYAN HJ, SASHI GOPAUL V, YANG H, LUNDBORG E, KIM S, FORMENTINI I, KOLKA CM. Dapagliflozin Improves Insulin Sensitivity in the Obese Prediabetic Canine Diabetes. 67: 113-LB. DOI: 10.2337/Db18-113-Lb  0.699
2016 Kim SP, Broussard JL, Kolka CM. Isoflurane and Sevoflurane Induce Severe Hepatic Insulin Resistance in a Canine Model. Plos One. 11: e0163275. PMID 27802272 DOI: 10.1371/Journal.Pone.0163275  0.638
2015 Kabir M, Iyer MS, Richey JM, Woolcott OO, Asare Bediako I, Wu Q, Kim SP, Stefanovski D, Kolka CM, Hsu IR, Catalano KJ, Chiu JD, Ionut V, Bergman RN. CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors. American Journal of Physiology. Endocrinology and Metabolism. 309: E747-58. PMID 26306598 DOI: 10.1152/Ajpendo.00196.2015  0.844
2015 Broussard JL, Kolka CM, Castro AV, Asare Bediako I, Paszkiewicz RL, Szczepaniak EW, Szczepaniak LS, Knutson KL, Kim SP, Bergman RN. Elevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation during diet-induced insulin resistance in dogs. Diabetologia. PMID 26254577 DOI: 10.1007/S00125-015-3721-6  0.758
2015 Woolcott OO, Richey JM, Kabir M, Chow RH, Iyer MS, Kirkman EL, Stefanovski D, Lottati M, Kim SP, Harrison LN, Ionut V, Zheng D, Hsu IR, Catalano KJ, Chiu JD, et al. Corrections: High-Fat Diet-Induced Insulin Resistance does not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets. Plos One. 10: e0131033. PMID 26075612 DOI: 10.1371/journal.pone.0131033  0.836
2015 Woolcott OO, Richey JM, Kabir M, Chow RH, Iyer MS, Kirkman EL, Stefanovski D, Lottati M, Kim SP, Harrison LN, Ionut V, Zheng D, Hsu IR, Catalano KJ, Chiu JD, et al. High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets. Plos One. 10: e0123558. PMID 25855974 DOI: 10.1371/Journal.Pone.0123558  0.853
2015 Castro AV, Woolcott OO, Iyer MS, Kabir M, Ionut V, Stefanovski D, Kolka CM, Szczepaniak LS, Szczepaniak EW, Asare-Bediako I, Paszkiewicz RL, Broussard JL, Kim SP, Kirkman EL, Rios HC, et al. Increase in visceral fat per se does not induce insulin resistance in the canine model. Obesity (Silver Spring, Md.). 23: 105-11. PMID 25322680 DOI: 10.1002/Oby.20906  0.885
2015 Broussard JL, Kolka CM, Castro AVB, Asare Bediako I, Paszkiewicz RL, Szczepaniak EW, Szczepaniak LS, Knutson KL, Kim SP, Bergman RN. Elevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation during diet-induced insulin resistance in dogs Diabetologia. DOI: 10.1007/s00125-015-3721-6  0.708
2014 Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance and comorbidities? Mechanisms of association. Arquivos Brasileiros De Endocrinologia E Metabologia. 58: 600-9. PMID 25211442 DOI: 10.1590/0004-2730000003223  0.673
2014 Bergman RN, Stefanovski D, Kim SP. Systems analysis and the prediction and prevention of Type 2 diabetes mellitus. Current Opinion in Biotechnology. 28: 165-70. PMID 24976265 DOI: 10.1016/J.Copbio.2014.05.007  0.605
2014 Ader M, Stefanovski D, Richey JM, Kim SP, Kolka CM, Ionut V, Kabir M, Bergman RN. Failure of homeostatic model assessment of insulin resistance to detect marked diet-induced insulin resistance in dogs. Diabetes. 63: 1914-9. PMID 24353184 DOI: 10.2337/Db13-1215  0.888
2014 Ader M, Stefanovski D, Kim SP, Richey JM, Ionut V, Catalano KJ, Hucking K, Ellmerer M, Van Citters G, Hsu IR, Chiu JD, Woolcott OO, Harrison LN, Zheng D, Lottati M, et al. Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity (Silver Spring, Md.). 22: 1238-45. PMID 24123967 DOI: 10.1002/Oby.20625  0.832
2014 Castro AVB, Kolka CM, Kim SP, Bergman RN. Obesity, Insulin resistance and comorbidities - mechanisms of association | Obesidade, Resistência à insulina e comorbidades - mecanismos de associação Arquivos Brasileiros De Endocrinologia E Metabologia. 58: 600-609. DOI: 10.1590/0004-2730000003223  0.64
2013 Kim SP. Mechanisms underlying restoration of hepatic insulin sensitivity with CB1 antagonism in the obese dog model. Adipocyte. 2: 47-49. PMID 23700552 DOI: 10.4161/adip.21890  0.491
2012 Kim SP, Woolcott OO, Hsu IR, Stefanoski D, Harrison LN, Zheng D, Lottati M, Kolka C, Catalano KJ, Chiu JD, Kabir M, Ionut V, Bergman RN, Richey JM. CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs. American Journal of Physiology. Endocrinology and Metabolism. 302: E1261-8. PMID 22374758 DOI: 10.1152/Ajpendo.00496.2011  0.859
2012 Woolcott OO, Bergman RN, Richey JM, Kirkman EL, Harrison LN, Ionut V, Lottati M, Zheng D, Hsu IR, Stefanovski D, Kabir M, Kim SP, Catalano KJ, Chiu JD, Chow RH. Simplified method to isolate highly pure canine pancreatic islets. Pancreas. 41: 31-8. PMID 21792087 DOI: 10.1097/Mpa.0B013E318221Fd0E  0.778
2011 Kabir M, Stefanovski D, Hsu IR, Iyer M, Woolcott OO, Zheng D, Catalano KJ, Chiu JD, Kim SP, Harrison LN, Ionut V, Lottati M, Bergman RN, Richey JM. Large size cells in the visceral adipose depot predict insulin resistance in the canine model. Obesity (Silver Spring, Md.). 19: 2121-9. PMID 21836643 DOI: 10.1038/Oby.2011.254  0.844
2011 Stefanovski D, Richey JM, Woolcott O, Lottati M, Zheng D, Harrison LN, Ionut V, Kim SP, Hsu I, Bergman RN. Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA. Plos One. 6: e18134. PMID 21479217 DOI: 10.1371/Journal.Pone.0018134  0.878
2009 Richey JM, Woolcott OO, Stefanovski D, Harrison LN, Zheng D, Lottati M, Hsu IR, Kim SP, Kabir M, Catalano KJ, Chiu JD, Ionut V, Kolka C, Mooradian V, Bergman RN. Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs. American Journal of Physiology. Endocrinology and Metabolism. 296: E1311-8. PMID 19366874 DOI: 10.1152/Ajpendo.90972.2008  0.771
2007 Hsu IR, Kim SP, Kabir M, Bergman RN. Metabolic syndrome, hyperinsulinemia, and cancer. The American Journal of Clinical Nutrition. 86: s867-71. PMID 18265480 DOI: 10.1093/Ajcn/86.3.867S  0.881
2007 Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. The American Journal of Medicine. 120: S3-8; discussion S29. PMID 17296343 DOI: 10.1016/J.Amjmed.2006.11.012  0.867
2007 Kim SP, Ellmerer M, Kirkman EL, Bergman RN. Beta-cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model. American Journal of Physiology. Endocrinology and Metabolism. 292: E1581-9. PMID 17284579 DOI: 10.1152/Ajpendo.00351.2006  0.795
2007 Kim SP, Catalano KJ, Hsu IR, Chiu JD, Richey JM, Bergman RN. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. American Journal of Physiology. Endocrinology and Metabolism. 292: E1590-8. PMID 17264230 DOI: 10.1152/Ajpendo.00669.2006  0.882
2007 Harrison LN, Stefanovski D, Woolcott O, Lottati M, Zheng D, Ionut V, Kim SP, Hsu I, Kabir M, Catalano KJ, Chiu JD, Bergman RN, Richey JM. Cannabinoid receptor antagonist rimonabant prevents weight gain in dogs on a high fat diet The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A694-D  0.766
2006 Ellmerer M, Hamilton-Wessler M, Kim SP, Huecking K, Kirkman E, Chiu J, Richey J, Bergman RN. Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake. Diabetes. 55: 1769-75. PMID 16731841 DOI: 10.2337/Db05-1509  0.892
2006 Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M, Hucking K, Ader M. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring, Md.). 14: 16S-19S. PMID 16642958 DOI: 10.1038/Oby.2006.277  0.854
2005 Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, Kabir M, Bergman RN. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes. 54: 862-71. PMID 15734866 DOI: 10.2337/Diabetes.54.3.862  0.841
2005 Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. American Journal of Physiology. Endocrinology and Metabolism. 288: E454-61. PMID 15522994 DOI: 10.1152/Ajpendo.00203.2004  0.872
2005 Liberty IF, Ionut V, Kim SP, Ader M, Lottati M, Bergman RN. 165 HIV-PROTEASE INHIBITOR TREATMENT, A NEW CANINE EXPERIMENTAL MODEL OF INSULIN RESISTANCE: Journal of Investigative Medicine. 53: S106.5-S107. DOI: 10.2310/6650.2005.00005.164  0.893
2004 Ellmerer M, Kim SP, Hamilton-Wessler M, Hücking K, Kirkman E, Bergman RN. Physiological hyperinsulinemia in dogs augments access of macromolecules to insulin-sensitive tissues. Diabetes. 53: 2741-7. PMID 15504953 DOI: 10.2337/Diabetes.53.11.2741  0.718
2003 Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes. 52: 2453-60. PMID 14514627 DOI: 10.2337/Diabetes.52.10.2453  0.894
2003 Ellmerer M, Hamilton-Wessler M, Kim SP, Dea MK, Kirkman E, Perianayagam A, Markussen J, Bergman RN. Mechanism of action in dogs of slow-acting insulin analog O346. The Journal of Clinical Endocrinology and Metabolism. 88: 2256-62. PMID 12727983 DOI: 10.1210/Jc.2002-021102  0.648
2002 van Citters GW, Kabir M, Kim SP, Mittelman SD, Dea MK, Brubaker PL, Bergman RN. Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding. The Journal of Clinical Endocrinology and Metabolism. 87: 5191-8. PMID 12414891 DOI: 10.1210/Jc.2002-020002  0.852
2001 Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Central role of the adipocyte in the metabolic syndrome. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 49: 119-26. PMID 11217141 DOI: 10.2310/6650.2001.34108  0.874
2000 Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M, Bergman RN. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes. 49: 2116-25. PMID 11118015 DOI: 10.2337/Diabetes.49.12.2116  0.882
Show low-probability matches.